Baxter EBIT Margin 2010-2023 | BAX
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Baxter (BAX) over the last 10 years. The current EBIT profit margin for Baxter as of December 31, 2023 is .
| Baxter EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2023-12-31 | $14.81B | $0.39B | 2.63% |
| 2023-09-30 | $14.66B | $0.33B | 2.24% |
| 2023-06-30 | $14.56B | $-2.50B | -17.18% |
| 2023-03-31 | $14.45B | $-2.22B | -15.37% |
| 2022-12-31 | $14.51B | $-2.24B | -15.46% |
| 2022-09-30 | $13.79B | $-2.43B | -17.63% |
| 2022-06-30 | $13.40B | $0.96B | 7.18% |
| 2022-03-31 | $12.91B | $1.12B | 8.70% |
| 2021-12-31 | $12.15B | $1.35B | 11.11% |
| 2021-09-30 | $12.45B | $1.73B | 13.92% |
| 2021-06-30 | $12.20B | $1.69B | 13.86% |
| 2021-03-31 | $11.82B | $1.60B | 13.51% |
| 2020-12-31 | $11.67B | $1.62B | 13.84% |
| 2020-09-30 | $11.53B | $1.75B | 15.14% |
| 2020-06-30 | $11.41B | $1.78B | 15.59% |
| 2020-03-31 | $11.53B | $1.80B | 15.60% |
| 2019-12-31 | $11.36B | $1.77B | 15.60% |
| 2019-09-30 | $11.14B | $1.62B | 14.56% |
| 2019-06-30 | $11.05B | $1.50B | 13.58% |
| 2019-03-31 | $11.06B | $1.54B | 13.88% |
| 2018-12-31 | $11.10B | $1.58B | 14.27% |
| 2018-09-30 | $11.08B | $1.49B | 13.42% |
| 2018-06-30 | $11.02B | $1.40B | 12.74% |
| 2018-03-31 | $10.79B | $1.37B | 12.67% |
| 2017-12-31 | $10.58B | $1.29B | 12.17% |
| 2017-09-30 | $10.43B | $1.30B | 12.49% |
| 2017-06-30 | $10.28B | $1.19B | 11.56% |
| 2017-03-31 | $10.26B | $0.91B | 8.87% |
| 2016-12-31 | $10.16B | $0.75B | 7.33% |
| 2016-09-30 | $10.12B | $0.62B | 6.13% |
| 2016-06-30 | $10.05B | $0.53B | 5.23% |
| 2016-03-31 | $9.94B | $0.55B | 5.48% |
| 2015-12-31 | $9.97B | $0.45B | 4.50% |
| 2015-09-30 | $10.15B | $0.46B | 4.55% |
| 2015-06-30 | $10.38B | $0.59B | 5.66% |
| 2015-03-31 | $12.06B | $1.16B | 9.61% |
| 2014-12-31 | $13.50B | $1.74B | 12.88% |
| 2014-09-30 | $15.03B | $2.09B | 13.93% |
| 2014-06-30 | $16.03B | $2.53B | 15.79% |
| 2014-03-31 | $15.55B | $2.70B | 17.36% |
| 2013-12-31 | $15.15B | $2.74B | 18.11% |
| 2013-09-30 | $14.33B | $2.72B | 18.99% |
| 2013-06-30 | $14.09B | $2.84B | 20.17% |
| 2013-03-31 | $14.00B | $2.79B | 19.95% |
| 2012-12-31 | $13.94B | $2.77B | 19.88% |
| 2012-09-30 | $14.03B | $2.87B | 20.47% |
| 2012-06-30 | $14.03B | $2.84B | 20.24% |
| 2012-03-31 | $14.00B | $2.89B | 20.68% |
| 2011-12-31 | $13.89B | $2.95B | 21.20% |
| 2011-09-30 | $13.80B | $2.84B | 20.61% |
| 2011-06-30 | $13.54B | $2.88B | 21.27% |
| 2011-03-31 | $13.20B | $2.75B | 20.82% |
| 2010-12-31 | $12.84B | $2.14B | 16.63% |
| 2010-09-30 | $12.82B | $2.35B | 18.31% |
| 2010-06-30 | $12.74B | $2.30B | 18.03% |
| 2010-03-31 | $12.67B | $2.35B | 18.52% |
| 2009-12-31 | $12.56B | $2.88B | 22.90% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $20.831B | $14.813B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.688B | 24.51 |
| Stryker (SYK) | United States | $127.423B | 31.59 |
| Medtronic (MDT) | Ireland | $107.939B | 15.28 |
| Boston Scientific (BSX) | United States | $101.215B | 33.65 |
| EssilorLuxottica (ESLOY) | France | $99.656B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.872B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 30.04 |
| ResMed (RMD) | United States | $27.097B | 27.09 |
| Terumo (TRUMY) | Japan | $25.416B | 35.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.968B | 16.07 |
| Koninklijke Philips (PHG) | Netherlands | $19.511B | 15.56 |
| Insulet (PODD) | United States | $11.713B | 61.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.842B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.136B | 24.24 |
| BellRing Brands (BRBR) | United States | $7.357B | 39.56 |
| Lantheus Holdings (LNTH) | United States | $4.415B | 11.40 |
| Haemonetics (HAE) | United States | $4.320B | 22.10 |
| Perrigo (PRGO) | Ireland | $4.132B | 11.82 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.536B | 16.72 |
| Envista Holdings (NVST) | United States | $3.475B | 13.22 |
| QuidelOrtho (QDEL) | United States | $2.702B | 9.81 |
| Neogen (NEOG) | United States | $2.666B | 25.65 |
| Green Thumb Industries (GTBIF) | United States | $2.566B | 81.33 |
| ICU Medical (ICUI) | United States | $2.382B | 17.77 |
| TG Therapeutics (TGTX) | United States | $2.202B | 712.50 |
| Owens & Minor (OMI) | United States | $1.959B | 18.80 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.941B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.788B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.662B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.475B | 45.95 |
| InMode (INMD) | Israel | $1.459B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.442B | 47.58 |
| Warby Parker (WRBY) | United States | $1.318B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.81 |
| AtriCure (ATRC) | United States | $1.121B | 0.00 |
| MacroGenics (MGNX) | United States | $1.015B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.905B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.701B | 15.15 |
| Cresco Labs (CRLBF) | United States | $0.695B | 0.00 |
| Evolus (EOLS) | United States | $0.678B | 0.00 |
| Quanterix (QTRX) | United States | $0.616B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.551B | 11.94 |
| Jin Medical (ZJYL) | China | $0.543B | 0.00 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.492B | 0.00 |
| PetIQ (PETQ) | United States | $0.489B | 18.24 |
| ZimVie (ZIMV) | United States | $0.437B | 26.75 |
| OraSure Technologies (OSUR) | United States | $0.423B | 7.00 |
| Biote (BTMD) | United States | $0.415B | 3.95 |
| Aurora Cannabis (ACB) | Canada | $0.405B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 41.42 |
| Zynex (ZYXI) | United States | $0.362B | 41.70 |
| Viemed Healthcare (VMD) | United States | $0.312B | 31.00 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.273B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.242B | 14.78 |
| Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.191B | 0.00 |
| Veru (VERU) | United States | $0.187B | 0.00 |
| Omeros (OMER) | United States | $0.179B | 0.00 |
| High Tide (HITI) | Canada | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.164B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.152B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.132B | 66.41 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.70 |
| InterCure (INCR) | Israel | $0.118B | 20.00 |
| Fonar (FONR) | United States | $0.101B | 8.70 |
| Cellectar Biosciences (CLRB) | United States | $0.100B | 0.00 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.086B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| Brainsway (BWAY) | Israel | $0.082B | 0.00 |
| Safety Shot (SHOT) | United States | $0.080B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.04 |
| Zevia PBC (ZVIA) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.54 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 75.27 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |